Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 9 papers. Top paper: “Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial”.
Andre C. Schuh, Eytan M. Stein, Pau Montesinos, Andrew H. Wei, Stéphane de Botton +12 more
Andreas Viardot, Nicole Baßermann, Christiane Wendl, Katrin Roth, Hartmut Goldschmidt +6 more
A Corbacioglu, V I Gaidzik, P Paschka, D Weber, M Heuser +42 more
Ling Du, Tamara J. Luck, Axel Benner, Julia Krzykalla, Insa Gathmann +25 more
Richard A. Larson, Dan Jones, Guido Marcucci, Thomas W. Prior, Jürgen Krauter +32 more
Jane E. Churpek, Tom Walsh, Sioḃán Keel, Marja Hakkarainen, Thomas Schroeder +30 more
Maral Saadati, Lars Bullinger, Richard A. Larson, Tiziana Ottone, Sergio Amadori +18 more
Pierre Fenaux, Marco Gobbi, Jiřı́ Mayer, Gail J. Roboz, Jürgen Krauter +21 more
Andrew H. Wei, Sumithra J. Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse‐Chieh Teh +24 more